EASD 2026
28 September - 2 October 2026
Advancing the amylin story: from scientific rationale to future cardiometabolic care
Meeting description
Wednesday, 30 September 2026
17:45 - 17:52
(CEST)
Opening perspectives: framing the amylin story
Carel le Roux
17:52 - 18:07
(CEST)
Amylin biology in action: translating mechanism into clinical potential
Thomas Lutz
18:07 - 18:32
(CEST)
CagriSema in focus: connecting phase 3 evidence across obesity and T2D
Arya M. Sharma, Akshay Jain
18:32 - 18:40
(CEST)
Amylin monotherapy: the road paved by cagrilintide
Arya M. Sharma, Akshay Jain
18:40 - 18:55
(CEST)
Zenagamtide and the next wave of amylin innovation
Vanita Aroda
18:55 - 19:10
(CEST)
Panel discussion: where could amylin-based therapies change clinical decision-making?
Carel le Roux, Thomas Lutz, Arya M. Sharma, Akshay Jain, Vanita Aroda
19:10 - 19:15
(CEST)
Closing perspective: the evolving role of amylin in cardiometabolic care
Carel le Roux
Keywords